Henry Anhalt, DO

//Henry Anhalt, DO

Dr. Anhalt was recently appointed chief medical officer of the T1D Exchange, a nonprofit organization that has created a new paradigm fostering collaboration among patients, physicians, researchers and industry to speed discovery of better therapies for type 1 diabetes. Henry oversees all aspects of the T1D Exchange’s groundbreaking research program and provides clinical leadership as the organization expands its capabilities and develops new initiatives to transform clinical care for patients, drive and support therapeutic advances and ensure patients are at the center of research. T1D Exchange has a clinic registry with more than 26,000 well-characterized T1D patients ranging in age from under a year to over 93; an online, nearly 13,000-strong patient/caregiver community, Glu; a unified clinic network of more than 230 collaborating clinicians and coordinators from 76 U.S. pediatric and adult sites seeing more than 150,000 patients; and a repository with biosamples from 2,000 participants, plus a Living Biobank composed of over 1,700 consented individuals. He serves as principal investigator on research grants and funding opportunities; oversees coordination with T1D Exchange’s partner, the Jaeb Center for Health Research, and manages relationships with Clinical Research Organizations, industry and foundation sponsors, regulatory and clinical consultants, and key opinion leaders. Henry’s recent work builds on more than 20 years in clinical practice, plus two decades’ worth of published research and presentations. He built and led three pediatric endocrinology divisions and has held academic appointments at a number of hospital systems. Most recently, he held a number of senior executive roles in industry including at Sanofi where as senior medical director he developed, led and executed the North America medical affairs strategy supporting the approval and launch of Toujeo® insulin. Prior to that, Anhalt served as chief medical officer and medical director of the artificial pancreas program at Animas, a Johnson & Johnson company. He is a pediatric endocrinologist who maintains an active practice with a special focus on T1D. Additionally, Henry is president of the board of trustees of Camp Nejeda a summer camp for children with T1D.